Suzhou MedicalSystem Technology Co., Ltd.

SHSE:603990 Stock Report

Market Cap: CN¥3.8b

Suzhou MedicalSystem Technology Management

Management criteria checks 1/4

Suzhou MedicalSystem Technology's CEO is Weng Kang, appointed in Jan 2023, has a tenure of 2.08 years. directly owns 6.88% of the company’s shares, worth CN¥263.22M. The average tenure of the management team and the board of directors is 2.1 years and 2.1 years respectively.

Key information

Weng Kang

Chief executive officer

CN¥2.6m

Total compensation

CEO salary percentagen/a
CEO tenure2.1yrs
CEO ownership6.9%
Management average tenure2.1yrs
Board average tenure2.1yrs

Recent management updates

Recent updates

Revenues Not Telling The Story For Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) After Shares Rise 28%

Feb 05
Revenues Not Telling The Story For Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) After Shares Rise 28%

Optimistic Investors Push Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) Shares Up 28% But Growth Is Lacking

Dec 05
Optimistic Investors Push Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) Shares Up 28% But Growth Is Lacking

Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) Held Back By Insufficient Growth Even After Shares Climb 29%

Oct 01
Suzhou MedicalSystem Technology Co., Ltd. (SHSE:603990) Held Back By Insufficient Growth Even After Shares Climb 29%

Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Subdued P/S Might Signal An Opportunity

Jun 26
Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Subdued P/S Might Signal An Opportunity

Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Shares Leap 30% Yet They're Still Not Telling The Full Story

Mar 08
Suzhou MedicalSystem Technology Co., Ltd.'s (SHSE:603990) Shares Leap 30% Yet They're Still Not Telling The Full Story

CEO

Weng Kang (56 yo)

2.1yrs

Tenure

CN¥2,600,000

Compensation

Mr. Weng Kang serves as Vice Chairman at Suzhou MedicalSystem Technology Co., Ltd., since January 9, 2023 and serves as its General Manager since January 10, 2023. He serves as General Manager and Executiv...


Leadership Team

NamePositionTenureCompensationOwnership
Weng Kang
Vice Chairman & GM2.1yrsCN¥2.60m6.88%
CN¥ 263.2m
Zhuzhu Zhou
Joint GM & Director2.1yrsCN¥2.59mno data
Jianghua Wang
Deputy GM & Director2.1yrsCN¥1.44m0.0077%
CN¥ 293.5k
Di Wu
Deputy General Manager2.1yrsCN¥2.21m0.019%
CN¥ 719.5k
Fengying Liu
Accounting Supervisorno datano datano data
Jie Chen
Deputy General Manager1yrno datano data

2.1yrs

Average Tenure

56yo

Average Age

Experienced Management: 603990's management team is considered experienced (2.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Weng Kang
Vice Chairman & GM12.3yrsCN¥2.60m6.88%
CN¥ 263.2m
Zhuzhu Zhou
Joint GM & Director2.1yrsCN¥2.59mno data
Jianghua Wang
Deputy GM & Director2.1yrsCN¥1.44m0.0077%
CN¥ 293.5k
Biao Li
Chairman of the Supervisory Board2.7yrsno data0.13%
CN¥ 4.8m
Ning Chen
Chairman2.8yrsno datano data
Dong Li
Independent Director2.1yrsCN¥147.20kno data
Jun Jiang
Supervisor2.1yrsno datano data

2.1yrs

Average Tenure

46yo

Average Age

Experienced Board: 603990's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 09:42
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Suzhou MedicalSystem Technology Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Guoping JiangEverbright Securities Co. Ltd.
Hai ShenTianfeng Securities Brokerage Co., Ltd
Biao ZengZhongtai Securities Co. Ltd.